Insulin resistance and adiposity in relation to serum β-carotene levels

Jose A Canas1, Ligeia Damaso, Astrid Altomare

  • 1Division of Pediatric Endocrinology and Metabolism, Nemours Children's Clinic, Jacksonville, FL 32207, USA. jcanas@nemours.org

Insights

Fruit and vegetable juice concentrate (FVJC) supplementation improved insulin resistance and reduced adiposity in overweight boys. This intervention also increased serum beta-carotene levels, highlighting its potential benefits for metabolic health.

Area of Science:

  • Pediatric Nutrition
  • Metabolic Health
  • Nutritional Supplementation

Background:

  • Childhood obesity is a growing concern, associated with increased insulin resistance and adiposity.
  • Subclinical inflammation and altered lipid profiles are common in overweight children.
  • Serum beta-carotene levels may serve as a biomarker for metabolic health in prepubertal boys.

Purpose of the Study:

  • To evaluate the impact of fruit and vegetable juice concentrate (FVJC) supplementation on key health markers in boys.
  • To compare the effects of FVJC versus placebo on serum beta-carotene, insulin resistance, and adiposity.
  • To assess changes in subclinical inflammation and related biomarkers.

Main Methods:

  • A 6-month randomized controlled trial involving 30 prepubertal boys (9 lean, 21 overweight).
  • Participants received nutrition counseling and were assigned to FVJC or placebo capsules.
  • Measurements included serum lipids, glucose, insulin, beta-carotene, adipokines, inflammatory markers, and abdominal fat mass.

Main Results:

  • Baseline beta-carotene inversely correlated with insulin resistance and abdominal fat mass.
  • FVJC supplementation significantly increased serum beta-carotene levels.
  • Overweight boys receiving FVJC showed decreased insulin resistance (HOMA-IR) and abdominal fat mass compared to placebo.

Conclusions:

  • Six-month FVJC supplementation, combined with nutritional counseling, improved beta-carotene levels in boys.
  • The intervention led to reduced adiposity and improved insulin resistance, particularly in overweight boys.
  • FVJC shows promise as a nutritional strategy to mitigate metabolic risks in childhood.
Abstract

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...